In The News

    • FEB 22 2016

    Understanding How an Anticancer Drug Works Can Pave the Way for Personalized Therapy

    Temple University highlights the work of Oncoceutics’ scientific founder Dr. Wafik El-Diery on his work elucidating the mechanism of action of ONC201. Understanding How an Anticancer Drug Works Can Pave the Way for Personalized Therapy

    • AUG 24 2015

    Oncoceutics Selected as Finalist for “The Buzz of BIO”

    The biotechnology trade group BIO has selected Oncoceutics as one of 10 finalists in a competition called “The Buzz of BIO”. Winners will be featured at the BIO Investor Forum that attracts leading pharmaceutical companies interested in the cutting edge of biotechnology. Vote here: https://www.bio.org/node/98373?utm_source=Highroads&utm_medium=email&utm_campaign=2015-08-24-BIF-2015-BuzzVoting&utm_term=Vote-Now-BTN